Table 1

Recommendations for patients with fragility fractures in patients aged 50 years and older

 Level of evidenceStrength of recommendationLevel of agreement
RecommendationAverage
Median
Range
1Fragility fractures should be managed in the context of a multidisciplinary clinical system, guaranteeing adequate preoperative assessment and preparation of patients, including adequate pain relief, appropriate fluid management and surgery within 48 hours of injuryIIAB9.8
10
8–10
2To improve functional outcome, and to reduce length of hospital stay and mortality, orthogeriatric comanagement should be provided, especially in elderly patients with hip fractureIAA9.2
10
0–10
3Appropriate treatment of the fractures in these, often elderly and multimorbid, patients with frail bones requires a balanced approach with regard to operative vs non-operative treatment and careful selection of fixation devices and techniquesIIIC9.3
10
7–10
4Each patient aged 50 years and over with a recent fracture should be evaluated systematically for the risk of subsequent fracturesIAA9.5
10
5–10
5Evaluation of the risk of subsequent fractures includes a review of clinical risk factors, DXA of the spine and hip, imaging of the spine for vertebral fractures and evaluation of falls risk and the identification of secondary osteoporosis, which together predict subsequent fracture riskIIIC9.3
10
6–10
6Implementation requires a local responsible lead, that is, a person/group that coordinates secondary fracture prevention based on guidelines, liaising between surgeons, rheumatologists/endocrinologists, geriatricians in case of elderly with a hip or other major fracture, and general practitionersIVD9.1
10
6–10
7An appropriate rehabilitation programmes should consist of both early postfracture introduction of physical training and muscle strengthening and the long-term continuation of balance training and multidimensional fall preventionIIAB9.5
10
5–10
8Patients should be educated about the burden of the disease, risk factors for fractures, follow-up and duration of therapyIVD9.2
10
5–10
9Non-pharmacological treatment is important in the prevention of fractures in high-risk patients; it includes at least an adequate intake of calcium and vitamin D, stopping smoking and limitation of alcohol intakeIVD9.3
10
6–10
10Pharmacological treatment should preferably use drugs that have been demonstrated to reduce the risk of vertebral, non-vertebral and hip fractures, and should be regularly monitored for tolerance and adherenceIBA9.9
10
9–10
  • DXA, dual energy xray absorptiometr.